Atlas Trials

Xuan Yin Ning Plus Bevacizumab for Malignant Pleural Effusion

Clinical trial NCT07670338 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07670338
Sponsor
Shanghai Chest Hospital
Status
NOT_YET_RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Malignant Pleural Effusions (Mpe)
Start date
2026-06-01
Primary completion
2028-09-01
Enrollment
308

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.